Find 4-Nitroestrone 3-Methyl Ether manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 14846-62-9, Chembl43326, G484l3u0o2, Nsc321803, Nsc-321803, Estra-1,3,5(10)-trien-17-one, 3-methoxy-4-nitro-
Molecular Formula
C19H23NO4
Molecular Weight
329.4  g/mol
InChI Key
QDFCXLJPTBSDPF-BFDPJXHCSA-N
FDA UNII
G484L3U0O2

4-Nitroestrone 3-Methyl Ether
4-Nitroestrone 3-Methyl Ether is a synthetic derivative of estradiol. 4-nitroestrone 3-methyl ether inhibits estrogen sulfotransferase (EST), a progesterone-induced secretory endometrial enzyme which affects estrogen receptor levels. This agent has been shown to be an effective growth inhibitor of some chemically induced animal mammary tumors. (NCI04)
1 2D Structure

4-Nitroestrone 3-Methyl Ether

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(8R,9S,13S,14S)-3-methoxy-13-methyl-4-nitro-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
2.1.2 InChI
InChI=1S/C19H23NO4/c1-19-10-9-12-11-5-7-16(24-2)18(20(22)23)14(11)4-3-13(12)15(19)6-8-17(19)21/h5,7,12-13,15H,3-4,6,8-10H2,1-2H3/t12-,13-,15+,19+/m1/s1
2.1.3 InChI Key
QDFCXLJPTBSDPF-BFDPJXHCSA-N
2.1.4 Canonical SMILES
CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4[N+](=O)[O-])OC
2.1.5 Isomeric SMILES
C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4[N+](=O)[O-])OC
2.2 Other Identifiers
2.2.1 UNII
G484L3U0O2
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 14846-62-9

2. Chembl43326

3. G484l3u0o2

4. Nsc321803

5. Nsc-321803

6. Estra-1,3,5(10)-trien-17-one, 3-methoxy-4-nitro-

7. 3-methoxy-4-nitro-estra-1,3,5(10)-trien-17-one

8. Nsc 321803

9. (8r,9s,13s,14s)-3-methoxy-13-methyl-4-nitro-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-one

10. Unii-g484l3u0o2

11. Schembl9362693

12. Dtxsid90163991

13. Zinc3780812

14. Bdbm50028411

15. Nci-321803

16. Nci60_002792

17. 3-methoxy-4-nitro-1,3,5(10)-estratrien-17-one

18. Estra-1,5[10]-trien-17-one, 3-methoxy-4-nitro-

19. Q27896339

20. 3-methoxy-13-methyl-4-nitro-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 329.4 g/mol
Molecular Formula C19H23NO4
XLogP33.3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass329.16270821 g/mol
Monoisotopic Mass329.16270821 g/mol
Topological Polar Surface Area72.1 Ų
Heavy Atom Count24
Formal Charge0
Complexity544
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty